Allarity Therapeutics Europe ApS
CVR number: 34623562
Venlighedsvej 1, 2970 Hørsholm
tel: 53639637
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -27 706.00 | -13 155.00 | -79 617.00 | -42 967.00 | -49 354.00 |
| Employee benefit expenses | -4 411.00 | -2 930.00 | -24.00 | -8 775.00 | -6 261.00 |
| Total depreciation | -7 006.00 | - 824.00 | - 333.00 | - 118 683.00 | - 196.00 |
| EBIT | -39 123.00 | -16 909.00 | -79 974.00 | - 170 425.00 | -55 811.00 |
| Other financial income | 4 238.00 | 6 952.00 | 3 735.00 | 1 752.00 | |
| Other financial expenses | -4 057.00 | -10 950.00 | -4 616.00 | -3 222.00 | - 219.00 |
| Net income from associates (fin.) | 37 201.00 | ||||
| Pre-tax profit | -38 942.00 | -20 907.00 | -43 654.00 | - 173 647.00 | -54 278.00 |
| Income taxes | 4 977.00 | 2 350.00 | -32 625.00 | 31 209.00 | 5 543.00 |
| Net earnings | -33 965.00 | -18 557.00 | -76 279.00 | - 142 438.00 | -48 735.00 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Development expenditure | 9 000.00 | 10 129.00 | 466 974.00 | 348 431.00 | 348 431.00 |
| Intangible rights | 682.00 | 425.00 | 526.00 | 396.00 | 274.00 |
| Intangible assets total | 9 682.00 | 10 554.00 | 467 500.00 | 348 827.00 | 348 705.00 |
| Buildings | 173.00 | 67.00 | 52.00 | 144.00 | 97.00 |
| Machinery and equipment | 41.00 | ||||
| Other tangible assets | 41.00 | ||||
| Tangible assets total | 173.00 | 67.00 | 52.00 | 185.00 | 138.00 |
| Holdings in group member companies | 8 653.00 | 8 653.00 | |||
| Other receivables | 211.00 | 217.00 | 349.00 | 951.00 | 511.00 |
| Investments total | 8 864.00 | 8 870.00 | 349.00 | 951.00 | 511.00 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 10 639.00 | 15 653.00 | 6 179.00 | 5 799.00 | 5 801.00 |
| Prepayments and accrued income | 446.00 | 57.00 | 898.00 | 1 797.00 | 669.00 |
| Current other receivables | 1 699.00 | 521.00 | 3 299.00 | 568.00 | 610.00 |
| Current deferred tax assets | 3 170.00 | 2 350.00 | 5 500.00 | 5 500.00 | 5 500.00 |
| Short term receivables total | 15 954.00 | 18 581.00 | 15 876.00 | 13 664.00 | 12 580.00 |
| Other current investments | 2 298.00 | ||||
| Cash and bank deposits | 5 607.00 | 100.00 | 12 717.00 | 2 316.00 | 302.00 |
| Cash and cash equivalents | 5 607.00 | 100.00 | 15 015.00 | 2 316.00 | 302.00 |
| Balance sheet total (assets) | 40 280.00 | 38 172.00 | 498 792.00 | 365 943.00 | 362 236.00 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 2 197.00 | 2 197.00 | 2 207.00 | 2 207.00 | 2 207.00 |
| Share premium account | 8 922.00 | 436 526.00 | 436 526.00 | 436 526.00 | |
| Retained earnings | -96 736.00 | - 139 623.00 | 23 830.00 | -52 537.00 | - 194 975.00 |
| Profit of the financial year | -33 965.00 | -18 557.00 | -76 279.00 | - 142 438.00 | -48 735.00 |
| Shareholders equity total | - 128 504.00 | - 147 061.00 | 386 284.00 | 243 758.00 | 195 023.00 |
| Provisions | 38 522.00 | 12 415.00 | 12 372.00 | ||
| Non-current owed to group member | 97 910.00 | 171 049.00 | 6 423.00 | ||
| Non-current liabilities total | 97 910.00 | 171 049.00 | 6 423.00 | ||
| Current trade creditors | 10 845.00 | 12 550.00 | 52 378.00 | 39 433.00 | 51 140.00 |
| Current owed to group member | 59 374.00 | 1 173.00 | 13 596.00 | 68 861.00 | 103 239.00 |
| Other non-interest bearing current liabilities | 655.00 | 461.00 | 1 589.00 | 1 476.00 | 462.00 |
| Current liabilities total | 70 874.00 | 14 184.00 | 67 563.00 | 109 770.00 | 154 841.00 |
| Balance sheet total (liabilities) | 40 280.00 | 38 172.00 | 498 792.00 | 365 943.00 | 362 236.00 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.